Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Tazobactam

An inhibitor of beta-lactamases, the enzymes bacteria use to destroy penicillins and cephalosporins. Patented in 1982 and in use since 1992, it is paired with piperacillin and ceftolozane to protect them and broaden their spectrum. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?On its own it has very little antibacterial activity: it acts as a 'bodyguard', binding irreversibly to bacterial enzymes and disabling them before they can attack the antibiotic.

TazobactamGo to the active ingredient →
TazobactamActive ingredientTazobactamCat. No. P-T025-001CAS 89786-04-9

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceTazobactam CRSEDQM code Y0002511Family Tazobactam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.